SEC FORM 4

SEC FORM 4SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simanovsky Michael

(Last)

(First)

(Middle)

25 DEFOREST AVENUE

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SONIDA SENIOR LIVING, INC. [ SNDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/10/2026		D		1,504,134	D	⁽⁶⁾	5,353,689	I	See footnotes⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾
Common Stock	08/10/2026		D		97,371	D	⁽⁶⁾	709,744	I	See footnotes⁽¹⁾⁽²⁾⁽⁴⁾⁽⁵⁾
Common Stock	08/10/2026		M		1,504,134	A	$32	6,857,823	I	See footnotes⁽¹⁾⁽³⁾⁽⁴⁾
Common Stock	08/10/2026		M		97,371	A	$32	807,115	I	See footnotes⁽¹⁾⁽⁴⁾⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Convertible Preferred Stock	$40	08/10/2026		A		38,742		11/03/2021	⁽⁶⁾	Common Stock	1,203,308	⁽¹⁾	38,742	I	See footnotes⁽¹⁾⁽³⁾⁽⁴⁾
Series A Convertible Preferred Stock	$40	08/10/2026		A		2,508		11/03/2021	⁽⁶⁾	Common Stock	77,897	⁽¹⁾	2,508	I	See footnotes⁽¹⁾⁽⁴⁾⁽⁵⁾
Series A Convertible Preferred Stock	$40	08/10/2026		D			38,742	08/10/2026	⁽⁶⁾	Common Stock	1,203,308	⁽¹⁾	0	I	See footnotes⁽¹⁾⁽³⁾⁽⁴⁾
Series A Convertible Preferred Stock	$40	08/10/2026		D			2,508	08/10/2026	⁽⁶⁾	Common Stock	77,897	⁽¹⁾	0	I	See footnotes⁽¹⁾⁽⁴⁾⁽⁵⁾
Series B Convertible Preferred Stock	$32	08/10/2026		A		38,742		08/10/2026	⁽⁷⁾	Common Stock	1,203,308	⁽¹⁾	38,742	I	See footnotes⁽¹⁾⁽³⁾⁽⁴⁾
Series B Convertible Preferred Stock	$32	08/10/2026		A		2,508		08/10/2026	⁽⁷⁾	Common Stock	77,897	⁽¹⁾	2,508	I	See footnotes⁽¹⁾⁽⁴⁾⁽⁵⁾
Series B Convertible Preferred Stock	$32	08/10/2026		M			38,742	08/10/2026	⁽⁷⁾	Common Stock	1,203,308	⁽¹⁾	0	I	See footnotes⁽¹⁾⁽³⁾⁽⁴⁾
Series B Convertible Preferred Stock	$32	08/10/2026		M			2,508	08/10/2026	⁽⁷⁾	Common Stock	77,897	⁽¹⁾	0	I	See footnotes⁽¹⁾⁽⁴⁾⁽⁵⁾

1. Name and Address of Reporting Person^*

Simanovsky Michael

(Last)

(First)

(Middle)

25 DEFOREST AVENUE

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Conversant Capital LLC

(Last)

(First)

(Middle)

25 DEFOREST AVENUE

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Conversant GP Holdings LLC

(Last)

(First)

(Middle)

25 DEFOREST AVENUE,

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Conversant Dallas Parkway (A) LP

(Last)

(First)

(Middle)

25 DEFOREST AVENUE

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Conversant Dallas Parkway (B) LP

(Last)

(First)

(Middle)

25 DEFOREST AVENUE

3RD FLOOR

(Street)

SUMMIT

NEW JERSEY

07901

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting Persons (as defined below), effected the unwinding of the previously reported (i) March 11, 2026 conversion of Series A Convertible Preferred Stock into 1,601,505 shares of Common Stock and (ii) March 11, 2026 amendment of the terms of Series A Convertible Preferred Stock (to reduce the conversion price to $32 per share of Common Stock). The Issuer, in accordance with Rule 16b-3, then entered an Exchange Agreement with the Reporting Persons, who exchanged their restored Series A Convertible Preferred Stock for the Issuer's newly authorized and issued Series B Convertible Preferred Stock, and immediately converted all Series B shares into 1,601,505 shares of Common Stock, each step approved under Rule 16b-3.

2. This Form 4 is being filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); and Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B") (collectively the filing persons are the "Reporting Persons").

3. Securities are held by Investor A.

4. Conversant GP is the general partner of each of Investor A and Investor B. Conversant Capital is the investment manager to each of Investor A and Investor B. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A and Investor B. Mr. Simanovsky, Conversant Capital and Conversant GP each disclaims beneficial ownership of the securities held by Investor A and Investor B except to the extent of his or its pecuniary interest therein.

5. Securities are held by Investor B.

6. There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.

7. There is no expiration date for the right of the holder of Series B Convertible Preferred Stock to convert.

Remarks:

Michael Simanovsky, Conversant Capital's Managing Partner, and Robert T. Grove, a Principal of Conversant Capital, serve as members of the Issuer's board of directors. On the basis of the relationship between Messrs. Simanovsky and Grove and the Reporting Person, the Reporting Person may be considered a director of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

	MICHAEL J. SIMANOVSKY by: /s/ Paul Dumaine, Attorney-in-fact for Michael J.Simanovsky	08/10/2026
	CONVERSANT CAPITAL LLC by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer	08/10/2026
	CONVERSANT GP HOLDINGS LLC by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer	08/10/2026
	CONVERSANT DALLAS PARKWAY (A) LP by: Conversant GP Holdings LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer	08/10/2026
	CONVERSANT DALLAS PARKWAY (B) LP by: Conversant GP Holdings LLC, its general partner by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)